KALARIS THERAPEUTICS INC
KLRS·482929106·US·Common Stock·Healthcare - Biotechnology-Activist
KLRS (KALARIS THERAPEUTICS INC) is held by 32 institutional investors as of Q2 2026. Largest holders: RTW INVESTMENTS, LP ($5.3M), Alyeska Investment Group, L.P. ($2.3M), VANGUARD CAPITAL MANAGEMENT LLC ($1.6M). Net institutional sentiment: Mixed.
32
Holders
(1 Elite)
$15M
Total Value
57% (28)
Consensus
16 buying - 12 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 13, 2026 · Insiders May 22, 2026 · Activists May 22, 2026 · Congress none
ActivistSBSamsara BioCapital, L.P.44.8%May 22, 2026
InsiderASAKKARAJU SRINIVASOther 4K shMay 20, 2026
InsiderASAKKARAJU SRINIVASBuy $1.2MMay 20, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 36
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer